Patient and Healthcare Professional Preferences for Prescription Weight Loss Medications in Australia: Two Discrete Choice Experiments.
Journal Information
Full Title: Patient Prefer Adherence
Abbreviation: Patient Prefer Adherence
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, General & Internal
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure SF and BK are employed by CaPPRe. CaPPRe has consulted to Abbvie, Amgen, AstraZeneca, Celgene, CSL Behring, Edwards, GSK, Ipsen, Janssen, Novo Nordisk, Roche, Sanofi, Shire and UCB, outside of the submitted work. AP is an employee of Novo Nordisk Australia. The authors report no other conflicts of interest in this work."
"This study was conducted by Community and Patient Preference Research (CaPPRe) and funded by Novo Nordisk. CaPPRe was responsible for carrying out all aspects of the research. Novo Nordisk was consulted on the research design, and were not involved in the data collection, analysis, or interpretation of the data. AP, an employee of Novo Nordisk is a co-author of the current manuscript."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025